EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Myriocin Restores Metabolic Homeostasis in dAGE-Exposed Mice via AMPK-PGC1α-Mediated Mitochondrial Activation and Systemic Lipid/Glucose Regulation

Libo He, Jinye Dang iD, Jingjing Li, Hairui Xue, Jiaxiu Cai, Guohua Cheng, Yuhui Yang, Zhiyi Liu, Binghua Liu, Yali Dai, Yu Zhang, Yating Huang und 3 weitere

Nutrients · 2025

DOI: 10.3390/nu17091549 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, 2025. Verfasst von Libo He und 14 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Bio-Resource and Eco-Environment of Ministry of Education, College of Life Sciences, Sichuan University, Chengdu 610065, China. Hauptthemen laut MEDLINE: Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha, AMP-Activated Protein Kinases, Lipid Metabolism, Fatty Acids, Monounsaturated. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Nature Science Foundation of Sichuan, China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Diet-derived advanced glycation end products (dAGEs) are closely associated with obesity and metabolic disorders. This study investigates the therapeutic potential of myriocin (Myr), a sphingolipid synthesis inhibitor, in counteracting dAGE-induced obesity and its underlying mechanisms.

Methods

Male C57BL/6J wild-type mice were randomly assigned to receive either a low-AGE diet or a high-AGE diet with or without the administration of myriocin for a duration of 24 weeks. At the end of the experimental period, blood samples, whole livers, and adipose tissues were harvested for subsequent biochemical, histological, and molecular analyses.

Results

Using a 24-week high-AGE diet mouse model, we demonstrate that Myr significantly reduces body weight gain (by 76%) and adipose tissue accumulation, while alleviating hepatic steatosis. Myr improves glucose homeostasis by lowering fasting blood glucose (a 44.5% reduction), enhancing oral glucose tolerance, and restoring hepatic glycolysis/gluconeogenesis balance via upregulating glucokinase and suppressing G6pc. Notably, Myr reduces serum LDL-C, TG, and TC levels by 52.3%, 51.8%, and 48.8%, respectively, and ameliorates liver dysfunction as evidenced by normalized ALT/AST activities. Metabolomics reveal Myr reshapes amino acid, carbohydrate, and lipid metabolism pathways. Mechanistically, Myr suppresses lipogenesis by downregulating Srebp1, Fasn, and Acc, while activating AMPK-PGC1α signaling to enhance mitochondrial biogenesis (a 2.1-fold increase in mtDNA) and thermogenesis via Ucp1 upregulation in brown and white adipose tissues.

Conclusions

Our findings unveil Myr as a novel dual regulator of lipid and glucose metabolism through AMPK-PGC1α-mediated mitochondrial activation, providing the first evidence of sphingolipid inhibition as a therapeutic strategy against dAGE-induced metabolic syndrome. This study establishes a multifaceted mechanism involving hepatic lipid regulation, adipose browning, and systemic metabolic reprogramming, advancing potential clinical applications for obesity-related disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaAMP-Activated Protein KinasesLipid MetabolismFatty Acids, MonounsaturatedMitochondriaGlycation End Products, AdvancedGlucoseAnimalsMaleMice, Inbred C57BLHomeostasisMiceLiverBlood GlucoseObesityFatty Liver

Stichwörter der Autor:innen

AMPKPGC1αadvanced glycation end productsmyriocinobesity

Substanzen

Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaAMP-Activated Protein KinasesthermozymocidinPpargc1a protein, mouseFatty Acids, MonounsaturatedGlycation End Products, AdvancedGlucoseBlood Glucose

Autor:innen und Institutionen

  • Key Laboratory of Bio-Resource and Eco-Environment of Ministry of Education, College of Life Sciences, Sichuan University, Chengdu 610065, China.
  • College of Food and Biological Engineering, Chengdu University, Chengdu 610106, China.
  • Laboratory of Molecular Biology, College of Medicine, Chengdu University, Chengdu 610106, China.
  • School of Pharmacy, Chengdu Medical College, Chengdu 610500, China.
  • College of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
  • College of Medical Technology, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.

ORCID-Profile: Jinye Dang, Jinlin Guo, Ke Liu

Förderung

  • Nature Science Foundation of Sichuan, China

Zitieren

APA

He, L., Dang, J., Li, J., Xue, H., Cai, J., Cheng, G., Yang, Y., Liu, Z., Liu, B., Dai, Y., Zhang, Y., Huang, Y., Sun, Y., Guo, J., & Liu, K. (2025). Myriocin Restores Metabolic Homeostasis in dAGE-Exposed Mice via AMPK-PGC1α-Mediated Mitochondrial Activation and Systemic Lipid/Glucose Regulation. Nutrients. https://doi.org/10.3390/nu17091549

Vancouver

He L, Dang J, Li J, Xue H, Cai J, Cheng G, et al. Myriocin Restores Metabolic Homeostasis in dAGE-Exposed Mice via AMPK-PGC1α-Mediated Mitochondrial Activation and Systemic Lipid/Glucose Regulation. Nutrients. 2025. doi:10.3390/nu17091549

BibTeX
@article{He2025,
  author = {He, Libo and Dang, Jinye and Li, Jingjing and Xue, Hairui and Cai, Jiaxiu and Cheng, Guohua and Yang, Yuhui and Liu, Zhiyi and Liu, Binghua and Dai, Yali and Zhang, Yu and Huang, Yating and Sun, Yiran and Guo, Jinlin and Liu, Ke},
  title = {Myriocin Restores Metabolic Homeostasis in dAGE-Exposed Mice via AMPK-PGC1α-Mediated Mitochondrial Activation and Systemic Lipid/Glucose Regulation},
  journal = {Nutrients},
  year = {2025},
  doi = {10.3390/nu17091549}
}
Kostenlos starten →